2014
DOI: 10.1016/j.mayocp.2014.01.017
|View full text |Cite
|
Sign up to set email alerts
|

Clinician's Checklist for Reading and Using an Article About Patient-Reported Outcomes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
23
0

Year Published

2015
2015
2020
2020

Publication Types

Select...
8
1
1

Relationship

1
9

Authors

Journals

citations
Cited by 23 publications
(23 citation statements)
references
References 36 publications
0
23
0
Order By: Relevance
“…The proliferation of studies reporting PROs led to an extension of the Consolidated Standards of Reporting Trials guidelines to specifically address the use of PROs in randomized trials 4 and instructions from the Food and Drug Administration regarding the use of PROs in trials for labeling of medical products. 5 Wu et al 6 recently published a checklist to help clinicians interpret research studies that use PROs. In fact, PROs have become so widespread that multiple major journals have published viewpoint articles suggesting that PROs be collected regularly in all clinical settings.…”
mentioning
confidence: 99%
“…The proliferation of studies reporting PROs led to an extension of the Consolidated Standards of Reporting Trials guidelines to specifically address the use of PROs in randomized trials 4 and instructions from the Food and Drug Administration regarding the use of PROs in trials for labeling of medical products. 5 Wu et al 6 recently published a checklist to help clinicians interpret research studies that use PROs. In fact, PROs have become so widespread that multiple major journals have published viewpoint articles suggesting that PROs be collected regularly in all clinical settings.…”
mentioning
confidence: 99%
“…26 Since then, further criteria have been published for evaluating the methodological quality of HRQOL instruments. [27][28][29][30][31][32] Recommendations and guidelines are included in the following discussions. Table 1 provides a checklist of the most important guidelines when conducting studies involving HRQOL data, and the short list of questions and/or an algorithm to guide the reviewer includes questions to direct reviews of studies that involve HRQOL data.…”
Section: Statistical and Reporting Considerationsmentioning
confidence: 99%
“…For many exposures, randomized controlled trials are implausible, and well-designed observational studies are the best alternative (Rothman and Greenland, 2005). Clinicians should also judge the degree to which a study simulates clinical practice and whether the results are generalizable to his/her own patient population (Wu et al, 2014). For example, mutations in NCSTN, PSENEN, and PSEN1, which affect the function of g-secretase, have been strongly associated with familial hidradenitis suppurativa in Chinese individuals.…”
Section: Replication Causality and Generalizabilitymentioning
confidence: 99%